Back to search
FDAFDA · Food and drugs·Recall number D-1079-2020

Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-982-01

Published April 8, 2020 · Recall initiated: April 1, 2020

Summary

FDA records drug Class II recall D-1079-2020, published April 8, 2020 and initiated April 1, 2020. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 25,944 bottles; Lot: Lot #: Q900580, Exp 9/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email if LISINOPRIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LISINOPRIL
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
U.S.A. Nationwide
UPC
0368180513018
Lot
Lot #: Q900580, Exp 9/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-982-01 recalled?

Yes. FDA published recall D-1079-2020 on April 8, 2020. Reported hazard: Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LISINOPRIL. UPC: 0368180513018.